TabsDetailsBasic DetailsDate Posted: Friday, December 8, 2017Status: In progressMedical Product: crizoatinib, erlotinib HCL, ipilimumab, nivolumab, pembrolizumabDescription: This request examines the incidence, prevalence, and occurrence of various Healthcare Common Procedure Coding System (HCPCS) codes for intravenous cancer drugs in the Sentinel Distributed Database (SDD). Read More Deliverables (2)Sentinel Summary Table Report: Use of Cancer Drugs (HCPCS)Sentinel Summary Table Report: Use of Cancer Drugs (Prevalent Use)Additional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2000 - August 31, 2015Study Type: Summary TableAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Sentinel Distributed Database (SDD)
